Watson Challenges Sunovion Patent on Xopenex

Drug Industry Daily
A A
Watson Laboratories has filed an ANDA to market generic versions of Sunovion Pharmaceuticals’ bronchospasm treatment Xopenex HFA prior to the patent’s expiration, sparking a lawsuit by Sunovion.

To View This Article:

Login

Subscribe To Drug Industry Daily